These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 23101262)
21. [Use of cycloferon in a combined treatment of chlamydial conjunctivitis]. Aznabaev MT; Latypova EA; Mal'khanov VB Vestn Oftalmol; 2003; 119(1):38-9. PubMed ID: 12608044 [TBL] [Abstract][Full Text] [Related]
22. [Peculiarities of immunomodulating therapy in an immunocompromised patient with allergies]. Klin Med (Mosk); 2011; 89(5):60-4. PubMed ID: 22242271 [TBL] [Abstract][Full Text] [Related]
24. [Efficiency of using cycloferon as part of combined therapy for chronic hepatitis C (a review of multicenter clinical trials)]. Sologub TV; Romantsev MG; Shul'diakov AA; Lin'kova IuN; Radchenko VG; Kovalenko AL Ter Arkh; 2010; 82(10):78-81. PubMed ID: 21341470 [TBL] [Abstract][Full Text] [Related]
26. Synergistic antiherpetic effect of acyclovir and mycophenolate mofetil following keratoplasty in patients with herpetic eye disease: first results of a randomised pilot study. Mayer K; Reinhard T; Reis A; Voiculescu A; Sundmacher R Graefes Arch Clin Exp Ophthalmol; 2003 Dec; 241(12):1051-4. PubMed ID: 12928902 [TBL] [Abstract][Full Text] [Related]
30. [Monitoring of side effects and estimation of cycloferon efficacy in treatment of children with frequent and prolonged diseases]. Lialikov SA; Romantsov MG; Bedin PG; Ermak SIu Antibiot Khimioter; 2012; 57(11-12):26-32. PubMed ID: 23700934 [TBL] [Abstract][Full Text] [Related]
31. [Cycloferon efficacy of therapy of chronic hepatitis B (results of randomized multicentre study)]. Sologub TV; Shul'diakov AA; Goriacheva LG; Baranova IP; Lin'kova IuN; Kovalenko AL; Romantsov MG Antibiot Khimioter; 2010; 55(9-10):37-41. PubMed ID: 21400753 [TBL] [Abstract][Full Text] [Related]
32. [Immunomodulators in the "gold standard" of the chronic viral hepatitis C therapy]. Romantsov MG; Kovalenko SN; Sologub TV; Anikina OV Antibiot Khimioter; 2008; 53(3-4):18-22. PubMed ID: 18942421 [TBL] [Abstract][Full Text] [Related]
33. [Comparative analysis of the effectiveness of antiviral therapy of children with infectious mononucleosis]. Baranova IP; Kurmaeva DIu Eksp Klin Farmakol; 2013; 76(8):47-9. PubMed ID: 24228491 [TBL] [Abstract][Full Text] [Related]
34. [The efficiency of combined therapy of herpes virus infection in HIV infected patients]. Papuashvili MN; Shchelkanov MIu Vopr Virusol; 2004; 49(2):25-9. PubMed ID: 15106380 [TBL] [Abstract][Full Text] [Related]
35. [The new interferon inducer Aktipol in the treatment of herpetic keratitis]. Akberova SI; Musaev Galbinur PI Vestn Oftalmol; 2000; 116(2):16-8. PubMed ID: 11055216 [TBL] [Abstract][Full Text] [Related]
36. [Cycloferon use in complex therapy of children with salmonellosis and yersiniosis infection]. Kvetnaia AS; Bekhtereva MK; Zhelezova LI; Kalinogorskaia OS Antibiot Khimioter; 2012; 57(3-4):9-16. PubMed ID: 22993934 [TBL] [Abstract][Full Text] [Related]
37. [Effectiveness of cycloferon liniment in a complex treatment, and monitoring of cytokine profile of gingival fluid of patients with paradontitis]. Grigorian SS; Barer GM; Postnova NV Stomatologiia (Mosk); 2010; 89(5):17-20. PubMed ID: 21207889 [No Abstract] [Full Text] [Related]
38. [INFLUENCE OF REAMBERIN® AND CYCLOFERON® ON CONCETRATION OF "AVERAGE MOLECULES" IN SERUM OF PATIENTS WITH RECCURENT DEPRESSIVE DISORDERS IN OUTPATIENT OBSERVATION]. Tereshina IF; Kut'ko II; Rachkauskas GS Lik Sprava; 2014; (7-8):93-8. PubMed ID: 26118092 [TBL] [Abstract][Full Text] [Related]
39. [USING INTERFERON INDUCTORS IN THERAPY OF PRE-SCHOOL-AGE PATIENTS WITH REACTIVATED EPSTEIN - BARR VIRUS INFECTION.]. Khmilevakaya SA; Zaitseva IA Eksp Klin Farmakol; 2016; 79(6):24-29. PubMed ID: 29782751 [TBL] [Abstract][Full Text] [Related]